References
- D’AmbrosioETortorellaPIannettiLManagement of uveitis-related choroidal neovascularization: from the pathogenesis to the therapyJ Ophthalmol2014201445042824868454
- Mauget-FaÿsseMMimounGRuiz-MorenoJMVerteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditisRetina200626439640316603957
- NeriPMercantiLMariottiCSalvoliniSGiovanniniALong-term control of choroidal neovascularization in quiescent congenital toxoplasma retinochoroiditis with photodynamic therapy: 4-year resultsInt Ophthalmol2010301515619183856
- OliveiraLBReisPAPhotodynamic therapy-treated choroidal neovascular membrane secondary to toxoplasmic retinochoroiditisGraefes Arch Clin Exp Ophthalmol2004242121028103015064953
- ArevaloJFAdanABerrocalMHIntravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 monthsRetina201131235336320890239
- MathurGGeorgeAESenPPaediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factorOman J Ophthalmol20147314114325378880
- KramerMAxer-SiegelRJaouniTBevacizumab for choroidal neovascularization related to inflammatory diseasesRetina201030693894420168273
- AdanAMateoCWolley-DodCSurgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditisAm J Ophthalmol2003135338638712614761
- UemuraAThomasMAVisual outcome after surgical removal of choroidal neovascularization in pediatric patientsArch Ophthalmol2000118101373137811030819
- DhingraNKellySMajidMABaileyCBDickADInflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatmentIndian J Ophthalmol201058131020029141
- SemeraroFMorescalchiFDuseSParmeggianiFGambicortiECostagliolaCAflibercept in wet AMD: specific role and optimal useDrug Des Devel Ther20137711722
- BraimahIZStewartMVidekarCDedhiaCJChhablaniJIntravitreal ziv-aflibercept for the treatment of choroidal neovascularisation associated with conditions other than age-related macular degenerationBr J Ophthalmol2017 Epub ahead of print
- RishiPVenkataramanARishiECombination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosisIndian J Ophthalmol2011591626421157079
- NessiFGuex-CrosierYAmbresinAZografosLPhotodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to toxoplasmic chorioretinal scarKlin Monbl Augenheilkd2004221537137315162283
- AtmacaLSSimsekTBatiogluFClinical features and prognosis in ocular toxoplasmosisJpn J Ophthalmol200448438639115295668
- ShahNJShahUNIntravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosisIndian J Ophthalmol201159431831921666322
- Ben YahiaSHerbortCPJenzeriSIntravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosisInt Ophthalmol200828431131618401552
- KianersiFNaderiBANaderiBZGhanbariHIntravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case seriesSemin Ophthalmol201530318118724175641
- WolfAThurauSKookDIntravitreal bevacizumab for choroidal neovascularization secondary to inflammationActa Ophthalmol2010887e295e29619860782